ArticleFrontiers in immunology2026

CTSL loss leads to anti-PD-1 immunotherapy resistance in lung cancer by suppressing the anti-tumor function of peripheral CD8

Ying Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.